Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Pingfu Fu
Affiliation
Case Western Reserve University
ORCID
Career Start Year
2000
Papers
273
H Index
54
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36374176
Effects of different diets used to induce obesity/metabolic syndrome on bladder function in rats.
Am J Physiol Regul Integr Comp Physiol
2023
37664409
Enhancing cardiovascular risk prediction through AI-enabled calcium-omics.
ArXiv
2023
37993218
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
Clin Lung Cancer
2023
38047216
Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation.
Adv Radiat Oncol
2023
36951656
Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV.
Cancer Med
2023
37207167
Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens.
Front Oncol
2023
37236435
Focal adhesion kinase activation is involved in contractile stimulation-induced detrusor muscle contraction in mice.
Eur J Pharmacol
2023
37102221
Survival in elderly patients with breast cancer with and without autoimmune disease.
Cancer Med
2023
37268691
CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma.
NPJ Precis Oncol
2023
37198173
Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer.
NPJ Breast Cancer
2023
37264091
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
NPJ Precis Oncol
2023
37396490
Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer.
Eur J Radiol Open
2023
36399634
Retinoblastoma Expression and Targeting by CDK4/6 Inhibitors in Small Cell Lung Cancer.
Mol Cancer Ther
2023
34740922
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I Trial.
Clin Cancer Res
2022
35648850
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors.
Sci Adv
2022
35438755
Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis.
JAMA Netw Open
2022
35644011
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines.
Hematol Oncol
2022
35727603
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
Clin Cancer Res
2022
35669420
Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings.
Front Oncol
2022
35640931
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng <i>et al</i>.
J Immunother Cancer
2022
35600350
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
Front Oncol
2022
35522898
Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation.
JCO Clin Cancer Inform
2022
35681675
Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC).
Cancers (Basel)
2022
36620600
Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.
Front Oncol
2022
36437821
An End-to-End Integrated Clinical and CT-Based Radiomics Nomogram for Predicting Disease Severity and Need for Ventilator Support in COVID-19 Patients: A Large Multisite Retrospective Study.
Front Radiol
2022
36427313
A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors.
Sci Adv
2022
36410944
Skin rash after immunomodulatory drugs for plasma cell neoplasms: effective practical corticosteroid desensitisation regimen.
BMJ Support Palliat Care
2022
36044718
Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function.
JCO Precis Oncol
2022
36277775
Machine learning derived ECG risk score improves cardiovascular risk assessment in conjunction with coronary artery calcium scoring.
Front Cardiovasc Med
2022
36309007
Deep-learning-based hepatic fat assessment (DeHFt) on non-contrast chest CT and its association with disease severity in COVID-19 infections: A multi-site retrospective study.
EBioMedicine
2022
36066461
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Cancer
2022
36051618
Racial disparities in biochemical recurrence of prostate cancer.
Am J Clin Exp Urol
2022
35256515
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab.
J Immunother Cancer
2022
35186748
Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer.
Front Oncol
2022
35007352
Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
J Pathol
2022
34853071
Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis.
Cancer Res
2022
34850048
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.
J Natl Cancer Inst
2022
35271708
Genetic variants of PKLR are associated with acute pain in sickle cell disease.
Blood Adv
2022
35115363
Computational image features of immune architecture is associated with clinical benefit and survival in gynecological cancers across treatment modalities.
J Immunother Cancer
2022
35053444
Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
2022
34390318
Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer.
Cancer Rep (Hoboken)
2022
32556884
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
Invest New Drugs
2021
33827757
Physical Activity and Sleep Measures Using a Fitness Tracking Device during Hematopoietic Cell Transplantation: A Pilot Study.
Transplant Cell Ther
2021
33743483
Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.
Eur J Cancer
2021
33546206
Socioeconomic Factors and Survival of Multiple Myeloma Patients.
Cancers (Basel)
2021
33651718
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.
J Clin Invest
2021
33677964
Peptide Derivatives of Retinylamine Prevent Retinal Degeneration with Minimal Side Effects on Vision in Mice.
Bioconjug Chem
2021
33856023
Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Hum Mol Genet
2021
34885040
Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis.
Cancers (Basel)
2021
34941201
Comparison of the effectiveness and safety of unilateral and bilateral percutaneous vertebroplasty for osteoporotic vertebral compression fractures: A protocol for systematic review and meta-analysis.
Medicine (Baltimore)
2021
1 - 50 of 273
Column Actions
Search
Recommended Authors
David C Qian
Winship Cancer Institute of Emory University
Career Start Year
2015
Number of shared co-authors
10
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
1
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year
2012
Number of shared co-authors
6
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
0
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year
2005
Number of shared co-authors
0
Kouros Owzar
Duke University
Career Start Year
2005
Number of shared co-authors
15
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year
2004
Number of shared co-authors
2
Minya Pu
University of California
Career Start Year
2003
Number of shared co-authors
0
Keyue Ding
Queen's University
Career Start Year
2002
Number of shared co-authors
9
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year
2002
Number of shared co-authors
0
Mark E Smolkin
University of Virginia
Career Start Year
2002
Number of shared co-authors
0
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year
2001
Number of shared co-authors
0
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year
2001
Number of shared co-authors
0
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year
1997
Number of shared co-authors
4
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
2
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
1
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
1
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year
1992
Number of shared co-authors
23
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year
1991
Number of shared co-authors
0
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
5
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year
1988
Number of shared co-authors
1
Mark Lawler
Queens University Belfast Belfast
Career Start Year
1988
Number of shared co-authors
2
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year
1988
Number of shared co-authors
1
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
1
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year
1984
Number of shared co-authors
3
Helen J Ross
Mayo Clinic
Career Start Year
1982
Number of shared co-authors
7
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Brian M Feldman
Co-authored papers
11
Neelesh Sharma
Co-authored papers
10
William R Diver
Co-authored papers
9
Nilanjan Chatterjee
Co-authored papers
9
Joseph F Fraumeni
National Cancer Institute
Co-authored papers
9
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers
9
Jarmo Virtamo
Co-authored papers
8
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers
8
Michael J Thun
Co-authored papers
8
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers
8
Demetrius Albanes
Co-authored papers
8
N??ria Malats
Spanish National Cancer Research Centre
Co-authored papers
7
David J Hunter
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers
7
Christopher J O'Donnell
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
7
Gerald L Andriole
Co-authored papers
6
Kevin B Jacobs
Co-authored papers
6
Margaret R Karagas
Co-authored papers
6
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers
6
Stephanie J Weinstein
Co-authored papers
6
Kent D Taylor
Co-authored papers
5
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers
5
Neil E Caporaso
National Cancer Institute, National Institutes of Health
Co-authored papers
5
Maria Teresa Landi
National Cancer Institute
Co-authored papers
5
Patricia Porter-Gill
Arkansas Children's Research Institute
Co-authored papers
5
Xiuqing Guo
Co-authored papers
5
Albert V Smith
University of Michigan School of Public Health ann arbor
Co-authored papers
4
Shih-Jen Hwang
and Blood Institute
Co-authored papers
4
Bruce M Psaty
Co-authored papers
4
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Co-authored papers
4
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Co-authored papers
4
1 - 30